Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

JAMA Cardiol. 2022 Nov 1;7(11):1175. doi: 10.1001/jamacardio.2022.3296.
No abstract available

Publication types

  • Comment

MeSH terms

  • Death, Sudden, Cardiac / prevention & control
  • Defibrillators, Implantable*
  • Humans
  • Polymorphic Catecholaminergic Ventricular Tachycardia
  • Tachycardia, Ventricular* / therapy